Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with MelanomaJedd D. Wolchok, Miguel‐Angel Perales, Paul B. Chapman et al.|Molecular Therapy|2007Cited by 107
Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced MelanomaMiguel‐Angel Perales, Jedd D. Wolchok, Jianda Yuan et al.|Molecular Therapy|2008Cited by 100
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.Jianda Yuan, Jedd D. Wolchok, Geoffrey Y. Ku et al.|PubMed|2009Cited by 80
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanomaJedd D. Wolchok, Jianda Yuan, Humilidad F. Gallardo et al.|Journal of Clinical Oncology|2007Cited by 6